News
No benefit of routine stress test POST-PCI in high-risk patients
- Author:
- Susan Jeffrey
Publish date: August 28, 2022
Routine functional testing provided no advantage on clinical outcomes over standard care among high-risk patients after intervention, suggesting ‘...
News
ALL-HEART: No benefit of allopurinol in ischemic heart disease
- Author:
- Susan Jeffrey
Publish date: August 28, 2022
Allopurinol failed to affect a composite of nonfatal MI, nonfatal stroke, or CV death, in a randomized trial that was ‘definitively neutral’ in...
News
Angiography can wait for cardiac arrest without ST-elevation
- Author:
- Susan Jeffrey
Publish date: August 31, 2021
Results of the TOMAHAWK trial show that immediate transfer for angiography after out-of-hospital arrest without ST-segment elevation provided no...
News
FDA approves dapagliflozin (Farxiga) for chronic kidney disease
- Author:
- Susan Jeffrey
Publish date: May 3, 2021
Based on results of the DAPA-CKD trial, the FDA has granted approval for the diabetes drug in patients with CKD at risk for disease progression....
Article
ACC issues guidance on cardiac implications of coronavirus
- Author:
- Susan Jeffrey
Publish date: February 14, 2020
The document provides information on the potential cardiac implications from analog viral respiratory pandemics and offers early clinical guidance...